EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
1 clinical trials · Condition
◉ Watch EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer (NCT07702305) | Henan Cancer Hospital | 2026-06-23 |
Track EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis automatically
Every clearance here is in the API, with alerts when new ones post.